Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

seekingalpha.com - Manshi Mamtora - European market rebound led by pharma gains (EUR:USD:)
European market rebound led by pharma gains (EUR:USD:)
Seeking Alpha

Follow us on Google for the latest stock news London (UKX) +0.12% at 9,877. Germany (DAX:IND) +0.10% at 24,307. Germany's import prices fell 1.9% Y/Y in November. France (CAC:IND) -0.08% at 8,114. In other parts of Europe, Spain's GDP expands 2.8%…

seekingalpha.com - Nilanjana Basu - Regencell Bioscience is the top performing pharma stock YTD (RGC:NASDAQ)
Regencell Bioscience is the top performing pharma stock YTD (RGC:NASDAQ)
Seeking Alpha

Follow us on Google for the latest stock news The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector…

marketbeat.com - Innate Pharma (NASDAQ:IPHA) Shares Up 2.3% - Should You Buy?
Innate Pharma (NASDAQ:IPHA) Shares Up 2.3% - Should You Buy?
MarketBeat

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) shares rose 2.3% during trading on Monday. The stock traded as high as $1.81 and last traded at $1.79. Approximately 36,311 shares were traded during mid-day trading, an increase of…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) EVP Sells $767,600.00 in Stock
Royalty Pharma (NASDAQ:RPRX) EVP Sells $767,600.00 in Stock
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $38.38, for a total value of $767,600.00.

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Receives Consensus Rating of 'Strong Buy' from Analysts
Zealand Pharma A/S (OTCMKTS:ZLDPF) Receives Consensus Rating of 'Strong Buy' from Analysts
MarketBeat

Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) have received an average rating of 'Strong Buy' from the eight ratings firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's Why
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's Why
MarketBeat

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report)'s share price hit a new 52-week high on Monday. The stock traded as high as $77.67 and last traded at $77.5410, with a volume of 50565 shares. The stock had previously closed at $76.30.

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 5.5% - Should You Sell?
Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 5.5% - Should You Sell?
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s stock price traded down 5.5% during trading on Monday. The company traded as low as $27.70 and last traded at $27.70. 3,055 shares were traded during trading…

businessinsider.com - Jennifer Sor - These are Citi's stock picks in its top sectors of the market next year
These are Citi's stock picks in its top sectors of the market next year
Business Insider

The investing playbook to follow in the new year homes in on three key sectors of the stock market, according to Citigroup. The bank's investment research arm unveiled its list of sector calls heading into the first quarter of 2026, which included…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0846 GMT – TrumpRx appears to offer lower-volume drugs at reduced prices, mainly for the uninsured, but…

seekingalpha.com - The Alpha Analyst - FHLC: Why Patience Matters More Than Precision (NYSEARCA:FHLC)
FHLC: Why Patience Matters More Than Precision (NYSEARCA:FHLC)
Seeking Alpha

Fidelity MSCI Health Care Index ETF offers long-term growth potential, leveraging demographic tailwinds and biotech innovation, but requires patience through cycles. FHLC's market-cap weighting enables dynamic exposure, reducing biotech risk in…

republicworld.com - Asian News International - India's Strong Growth Cushions Impact Of US Tariffs, FTAs Driving Market Diversification: IIFT VC
India's Strong Growth Cushions Impact Of US Tariffs, FTAs Driving Market Diversification: IIFT VC
Republic World

India's strong economic growth has helped cushion the impact of higher U.S. tariffs on key export sectors, allowing the country to remain resilient while accelerating free trade agreements to diversify markets, boost services exports and attract…

thestar.com.my - Trading ideas: Crest Builder, EMCC, Yinson, Betamek, SSBB, George Kent, Kim Loong, AME Elite, Coastal Contracts, MNHB, Citaglobal
Trading ideas: Crest Builder, EMCC, Yinson, Betamek, SSBB, George Kent, Kim Loong, AME Elite, Coastal Contracts, MNHB, Citaglobal
The Star Online

Markets Crest Builder's unit CBTECH has secured a RM73.9mil subcontract for electrical and ELV works at a mixed-use development in Jalan P. Ramlee, bolstering earnings visibility from 2026 onwards. EMCC has secured approval from the Housing and…

dynamitenews.com - Sona Saini - Indian Stock Market turns red after flat start; Experts urge long-term focus | Dynamite News
Indian Stock Market turns red after flat start; Experts urge long-term focus | Dynamite News
News: Today's News Headlines & Daily Updates from Sports, Movies, Politics, Business | Dynamite News

Indian stock market opened positively on Tuesday, December 23, but turned red shortly after. BSE Sensex fell 163 points, while NSE Nifty dropped below 26,135. PowerGrid, Tata Steel, and Titan were top gainers, while TCS, Tech Mahindra, and Asian…

ciol.com - CIOL Bureau - UST and IIT Madras Incubation Cell Join Hands to Accelerate Deeptech Healthcare Startups
UST and IIT Madras Incubation Cell Join Hands to Accelerate Deeptech Healthcare Startups
CIOL

UST, an AI and technology transformation solutions company, has recently signed a Memorandum of Understanding (MoU) with the IIT Madras Incubation Cell (IITMIC), to foster innovation, entrepreneurship, and research-driven solutions in the…

cnbc.com - Annika Kim Constantino - FDA approves first GLP-1 pill for obesity from Novo Nordisk
FDA approves first GLP-1 pill for obesity from Novo Nordisk
CNBC

The FDA has approved the first-ever GLP-1 pill from Wegovy maker Novo Nordisk. Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January for $149 per month. The approval gives Novo Nordisk a head start over chief…

Receive a Daily briefing on Pharma Industry News

Get Started